Fahed Al-Marzooqi - 10 Jun 2025 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Role
Director
Signature
/s/ Elizabeth Keiley, as Attorney-in-fact
Issuer symbol
VTVT
Transactions as of
10 Jun 2025
Net transactions value
+$66,360
Form type
4
Filing time
12 Jun 2025, 16:25:07 UTC
Previous filing
27 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Al-Marzooqi Fahed Director C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, SUITE 310, HIGH POINT /s/ Elizabeth Keiley, as Attorney-in-fact 12 Jun 2025 0001928247

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTVT Director stock option (right to buy) Award $66,360 +4,000 +42% $16.59 13,555 10 Jun 2025 Class A Common Stock 4,000 $16.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of June 10, 2026, and the date of the 2026 annual general meeting of shareholders, subject to the director's continued service on the board of directors through such vesting.

Remarks:

Exhibit 24: Power of Attorney